A Materials Acceleration Platform for Organic Laser Discovery

May 31, 2022

ChemRxiv

Conventional materials discovery is a laborious and time-consuming process that can take decades from initial conception of the material to commercialization. Recent developments in materials acceleration platforms promise to accelerate materials discovery using automation of experiments coupled with machine learning. However, most of the automation efforts in chemistry focus on synthesis and compound identification, with integrated target property characterization receiving less attention. In this work, we introduce an automated platform for the discovery of molecules as gain mediums for organic semiconductor lasers, a problem that has been challenging for conventional approaches. Our platform encompassed automated lego-like synthesis, product identification, and optical characterization that can be executed in a fully integrated end-to-end fashion. Using this workflow to screen organic laser candidates, we have discovered 8 potential candidates for organic lasers. We tested the lasing threshold of 4 molecules in thin-film devices and found 2 molecules with state-of-the-art performance. These promising results show the potential of automated synthesis and screening for accelerated materials development.

For details

A Materials Acceleration Platform for Organic Laser Discovery

Tony C Wu 1, Andrés Aguilar Granda 1, Kazuhiro Hotta 1,5, Sahar Alasvand Yazdani 2, Robert Pollice 1, Jenya Vestfrid 1, Han Hao 1, Cyrille Lavigne 1, Martin Seifrid 1, Nicholas Angello 3, Fatima Bencheikh 2, Jason E. Hein 4, Martin Burke 3, Chihaya Adachi 2, Alán Aspuru-Guzik 1

  1. Department of Chemistry, University of Toronto, Toronto, ON M5S 3H6, Canada
  2. Center for Organic Photonics and Electronics Research, Kyushu University, Fukuoka 819-0395, Japan
  3. Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA
  4. Department of Chemistry, University of British Columbia, Vancouver, BC V6T 1Z1, Canada
  5. Science & Innovation Center, Mitsubishi Chemical Corporation, Yokohama, 227-8502, Japan

ChemRxiv
https://doi.org/10.26434/chemrxiv-2022-9zm65

For more information about Chemspeed solutions:

ISYNTH

Contact us to learn more about this exciting article:

https://www.chemspeed.com/contact-us/

Other Recent News

Discover more news articles you might be interested in

Read more about Toward fully autonomous closed-loop molecular discovery – A case study on JAK targets
News Picture 1 1 V2
Featured
Feb
3

Toward fully autonomous closed-loop molecular discovery – A case study on JAK targets

Bridging AI and self-driving laboratories, we introduce the first fully-automated, closed-loop molecular discovery cycle, exemplified by the identification of novel JAK inhibitors. With minimal human intervention, we combined AI-driven molecular design and retrosynthesis with IBM’s synthesis automation system RoboRXN and Arctoris’ Ulysses platform for automated in-vitro screening.

Read more about Altana tests coatings for the industry in a unique high-throughput facility worldwide / Altana testet Lacke fuer die Industrie in weltweit einmaliger Hochdurchsatzanlage
News Picture 1 1 V2
Featured
Jan
30

Altana tests coatings for the industry in a unique high-throughput facility worldwide / Altana testet Lacke fuer die Industrie in weltweit einmaliger Hochdurchsatzanlage

VDI news / nachrichten

Up to 220 paint samples per day go through a fully automated screening in a unique testing facility at Byk in Wesel. / Bis zu 220 Lackproben pro Tag durchlaufen ein vollautomatisches Screening in einer weltweit einmaligen Pruefanlage bei Byk in Wesel.

Read more about Asymmetric hydrogenation of olefins with transition metal-based catalysts: practical insights from screening to production of APIs
News Picture 1 1 V2
Featured
Jan
20

Asymmetric hydrogenation of olefins with transition metal-based catalysts: practical insights from screening to production of APIs

Selective hydrogenation plays a critical role in modern synthetic chemistry, particularly in the pharmaceutical industry, where the production of chiral molecules with high enantiomeric purity is essential for the efficacy and safety of active pharmaceutical ingredients (APIs). 

© Chemspeed Technologies 2026